Maze Therapeutics, Inc.
MAZE
$11.18
-$0.08-0.71%
NASDAQ
| 03/31/2025 | 12/31/2024 | 03/31/2024 | |||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 49.57% | 31.55% | 0.00% | ||
| Total Receivables | -- | -- | -- | ||
| Inventory | -- | -- | -- | ||
| Prepaid Expenses | 9.76% | 14.36% | -- | ||
| Finance Division Loans and Leases Current | -- | -- | -- | ||
| Total Finance Division Other Current Assets | -- | -- | -- | ||
| Other Current Assets | -- | -- | -- | ||
| Total Current Assets | 48.61% | 30.99% | -- | ||
|
|
|||||
| Total Current Assets | 48.61% | 30.99% | -- | ||
| Net Property, Plant & Equipment | -3.75% | -3.28% | -- | ||
| Long-term Investments | -- | -- | -- | ||
| Goodwill | -- | -- | -- | ||
| Total Other Intangibles | -- | -- | -- | ||
| Finance Div Loans & Leases LT | -- | -- | -- | ||
| Total Finance Div Other LT Assets | -- | -- | -- | ||
| Total Other Assets | -51.57% | 17.93% | -- | ||
| Total Assets | 38.37% | 24.97% | -- | ||
|
|
|||||
| Total Accounts Payable | 23.98% | 90.47% | -- | ||
| Total Accrued Expenses | -18.17% | 20.50% | -- | ||
| Short-term Debt | -- | -- | -- | ||
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | ||
| Finance Division Debt Current | 0.91% | 0.32% | -- | ||
| Total Finance Division Other Current Liabilities | -- | -- | -- | ||
| Total Other Current Liabilities | -- | -- | -- | ||
| Total Current Liabilities | -9.95% | 17.76% | -- | ||
|
|
|||||
| Total Current Liabilities | -9.95% | 17.76% | -- | ||
| Long-Term Debt | -- | -- | -- | ||
| Short-term Debt | -- | -- | -- | ||
| Capital Leases | -3.85% | -3.51% | -- | ||
| Finance Division Debt Non Current | -- | -- | -- | ||
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | ||
| Total Other Liabilities | 3.82% | -4.25% | -- | ||
| Total Liabilities | -6.57% | -53.13% | -- | ||
|
|
|||||
| Common Stock & APIC | 1,346.28% | 61.00% | -- | ||
| Retained Earnings | -9.15% | -14.19% | -- | ||
| Treasury Stock & Other | -- | -- | -- | ||
| Total Common Equity | 193.86% | -9.37% | 0.00% | ||
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | ||
| Preferred Stock Non Redeemable | -- | -- | -- | ||
| Preferred Stock Convertible | -- | 32.35% | -- | ||
| Preferred Stock, Others | -- | -- | -- | ||
| Total Preferred Equity | -- | 32.35% | 0.00% | ||
|
|
|||||
| Total Common Equity | 193.86% | -9.37% | 0.00% | ||
| Total Preferred Equity | -- | 32.35% | 0.00% | ||
| Total Minority Interest | -- | -- | -- | ||
| Total Equity | 48.33% | 98.15% | 0.00% | ||
|
|
|||||